Position in PFE
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$2,088,915
-$358,565 QoQ
Shares Held
86,749
-0.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#941
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Summit Financial Wealth Advisors, LLC holds $11,793,001 across 10 Drug Manufacturers - General names. PFE ranks #1 (17.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
This page
|
86,749 | $2,088,915 | |
| 2 | JNJ |
Johnson & Johnson
|
7,700 | $1,955,569 | |
| 3 | LLY |
ELI LILLY & Co
|
1,335 | $1,601,239 | |
| 4 | ABBV |
AbbVie Inc.
|
6,343 | $1,596,152 | |
| 5 | MRK |
Merck & Co., Inc.
|
10,611 | $1,363,513 | |
| 6 | AMGN |
Amgen Inc
|
2,344 | $848,809 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
12,990 | $748,483 | |
| 8 | NVO |
Novo Nordisk A S
|
15,600 | $747,864 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,088,915 | 86,749 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $2,447,480 | 87,161 | Shares | Sole | 2026-05-26 | |
| 2025-12-31 | $2,227,603 | 89,462 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $2,286,651 | 89,743 | Shares | Sole | 2025-10-03 | |
| 2025-06-30 | $2,528,232 | 104,300 | Shares | Sole | 2025-09-29 | |
| 2025-03-31 | $2,700,179 | 106,558 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,839,028 | 107,012 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,263,021 | 78,197 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,935,572 | 69,177 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $868,630 | 31,302 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $350,086 | 12,160 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $323,971 | 9,767 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $455,565 | 12,420 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $326,604 | 8,005 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $379,278 | 7,402 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $323,911 | 7,402 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $7,122,720 | 135,852 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $6,961,718 | 134,474 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $9,787,006 | 165,741 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $6,803,665 | 158,188 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $6,116,243 | 156,186 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $5,482,975 | 151,338 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $5,463,119 | 148,414 | Shares | Sole | 2021-01-11 | |
| 2020-09-30 | $5,597,405 | 152,518 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $4,996,401 | 152,795 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $4,905,361 | 150,287 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||